Skip to main content

Table 4 Multivariate Cox proportion hazards model for OS showing elevated LAG3 immunohistochemical expression as an independent prognostic biomarker in MPM

From: LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study

  

mRNA

  

IHC

 

Covariate

HR

95% CI

P value

HR

95% CI

P value

Age

1.0176

0.9887–1.048

0.2374

1.0099

0.9480–1.07776

0.7616

Male/Female

0.8837

0.4837–1.6143

0.6909

0.2613

0.0812–0.8409

0.0351

Stage

 II vs. I

0.5766

0.2357–1.4105

0.2277

0.8769

0.2192–3.5076

0.8527

 III vs. I

0.6688

0.3061–1.4612

0.3131

4.2209

1.0627–16.7644

0.0407

 IV vs. I

0.6920

0.2855–1.6772

0.4150

14.1624

2.3848–84.1033

0.0035

LAG3

0.8779

0.7643–1.0050

0.0592

0.2255

0.0610–0.8337

0.0197

  1. mRNA expression is from TCGA (The Cancer Genome Atlas), and immunohistochemical expression is from our cohort
  2. OS Overall survival, MPM Malignant pleural mesothelioma, IHC Immunohistochemistry, HR Hazard ratio, CI Confidence interval